bpc-157 regulatory status fda not approved peptide BPC-157: The Real Reason Why It's This is the first vote

In medial collateral ligament (MCL) injury models, BPC-157 administered intraperitoneally (10 g or 10 ng/kg once daily), topically as a cream layer, or orally in drinking water consistently produced functional, biomechanical, macroscopic, and histological healing improvements throughout the 90-day study period

Oral BPC-157 for gut support is often taken on an empty stomach, while an injection for a specific injury is placed near the site

(PubMed) Sharabi A, Cohen E, Sulkes J, Garty M

The 50 mg setup is far easier to draw accurately (20 units is a clean, mid-barrel mark) because the higher concentration and larger per-dose amount land on a bigger, more forgiving volume